Senti Biosciences (SNTI) Shares Outstanding (Diluted Average) (2021 - 2025)

Senti Biosciences has reported Shares Outstanding (Diluted Average) over the past 5 years, most recently at $22.5 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Diluted Average) at $22.5 million for Q4 2025, up 389.2% from a year ago — trailing twelve months through Dec 2025 was $22.5 million (up 389.2% YoY), and the annual figure for FY2025 was $22.5 million, up 389.2%.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $22.5 million at Senti Biosciences, up from $20.8 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for SNTI hit a ceiling of $44.1 million in Q1 2023 and a floor of $2.9 million in Q3 2021.
  • Median Shares Outstanding (Diluted Average) over the past 5 years was $4.6 million (2024), compared with a mean of $13.2 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): skyrocketed 1398.5% in 2022 and later tumbled 89.8% in 2023.
  • Senti Biosciences' Shares Outstanding (Diluted Average) stood at $2.9 million in 2021, then soared by 796.58% to $26.1 million in 2022, then tumbled by 83.01% to $4.4 million in 2023, then grew by 3.58% to $4.6 million in 2024, then soared by 389.2% to $22.5 million in 2025.
  • The last three reported values for Shares Outstanding (Diluted Average) were $22.5 million (Q4 2025), $20.8 million (Q3 2025), and $26.1 million (Q2 2025) per Business Quant data.